Back to top

Image: Bigstock

Can The Uptrend Continue for Clovis Oncology (CLVS)?

Read MoreHide Full Article

Investors certainly have to be happy with Clovis Oncology, Inc. (CLVS - Free Report) and its short term performance. After all, the stock has jumped by 18.2% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. This is certainly a good trend, but investors are probably asking themselves, can this positive trend continue for CLVS?

While we can never know for sure, it is pretty encouraging that estimates for CLVS have moved higher in the past few weeks, meaning that analyst sentiment is moving in the right way. Plus, the stock actually has a Zacks Rank #2 (Buy), so the recent move higher for this spotlighted company may definitely continue over the next few weeks.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Clovis Oncology, Inc. (CLVS) - free report >>

Published in